Zobrazeno 1 - 10
of 39
pro vyhledávání: '"A. Lianne Messchendorp"'
Autor:
Pim Bouwmans, S.Reshwan K. Malahe, A. Lianne Messchendorp, Priya Vart, Céline Imhof, Jan-Stephan F. Sanders, Ron T. Gansevoort, Aiko P.J. de Vries, Alferso C. Abrahams, Frederike J. Bemelman, Johanna P.M. Vervoort, Luuk B. Hilbrands, Marc A.G.J. ten Dam, René M.A. van den Dorpel, Theo Rispens, Maurice Steenhuis, Marlies E.J. Reinders, Marc H. Hemmelder
Publikováno v:
International Journal of Infectious Diseases, Vol 142, Iss , Pp 106990- (2024)
Background: The burden of post COVID-19 condition (PCC) is not well studied in patients with advanced kidney disease. Methods: A large prospective cohort of SARS-CoV-2 vaccinated patients with chronic kidney disease stages G4–G5 (CKD G4/5), on dial
Externí odkaz:
https://doaj.org/article/4c7e82b3ce614dea97d67f214a7541b0
Autor:
Yvette den Hartog, S. Reshwan K. Malahe, Wim J. R. Rietdijk, Marjolein Dieterich, Lennert Gommers, Daryl Geers, Susanne Bogers, Debbie van Baarle, Dimitri A. Diavatopoulos, A. Lianne Messchendorp, Renate G. van der Molen, Ester B. M. Remmerswaal, Frederike J. Bemelman, Ron T. Gansevoort, Luuk B. Hilbrands, Jan-Stephan Sanders, Corine H. GeurtsvanKessel, Marcia M. L. Kho, Marlies E. J. Reinders, Rory D. de Vries, Carla C. Baan, on behalf of RECOVAC Consortium
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Cytokines are regulators of the immune response against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting CD4+ and CD8+ memory T cells to the SARS-CoV-2-specific humoral immune resp
Externí odkaz:
https://doaj.org/article/1ffaa3b146d545b9acd6be2e7099edbb
Autor:
Sophie C. Frölke, Pim Bouwmans, A. Lianne Messchendorp, Johanna P.M. Vervoort, Alferso C. Abrahams, Aiko P.J. de Vries, Pythia T. Nieuwkerk, Marc H. Hemmelder, Ron T. Gansevoort, Luuk B. Hilbrands, Marlies E.J. Reinders, Jan-Stephan F. Sanders, Frederike J. Bemelman, Suzanne E. Geerlings, C. Imhof, C. Idzinga, C. Siegert, C.C. Baan, C.J.A.M. Konings, C. van Kessel, D. van Baarle, D.A. Diavatopoulos, D. Standaar, E. ten Hoope, E. Til, E.B.M. Remmerswaal, F. van der Klis, H.R. Fritsen, I. Stijnman, J.N. Brinkman, J. Cheng, L. den Biggelaar, M. ten Dam, M. Steenhuis, M. Zwerink, M.H.J. Braks, M. Willems, M.L. Kho, N. Rots, P. Vart, R.G. van der Molen, R.M.A. van den Dorpel, R.S.R.K. Malaha, R.C.G. ter Meulen, T. Rispens, T. Steenvoorden, T. de Ronde, V.J.P. Peters, W.S. Konijn, W.M.T. Janssen, W.J. Bos, Y.M.R. Adema, Y. Vegting
Publikováno v:
EClinicalMedicine, Vol 62, Iss , Pp 102103- (2023)
Summary: Background: Kidney transplant recipients (KTRs) were advised to tightly adhere to government recommendations to curb the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) because of a high risk of morbidity and mortality
Externí odkaz:
https://doaj.org/article/2b53151bf4f04e7f8da35249bd401c82
Autor:
A. Lianne Messchendorp, Jan-Stephan F. Sanders, Alferso C. Abrahams, Frederike J. Bemelman, Pim Bouwmans, René M. A. van den Dorpel, Luuk B. Hilbrands, Céline Imhof, Marlies E. J. Reinders, Theo Rispens, Maurice Steenhuis, Marc A. G. J. ten Dam, Priya Vart, Aiko P. J. de Vries, Marc H. Hemmelder, Ron T. Gansevoort, RECOVAC Investigators
Publikováno v:
Viruses, Vol 16, Iss 1, p 114 (2024)
Kidney transplant recipients (KTRs) elicit an impaired immune response after COVID-19 vaccination; however, the exact clinical impact remains unclear. We therefore analyse the relationship between antibody levels after vaccination and the risk of COV
Externí odkaz:
https://doaj.org/article/be6664aebcf949b8b71a3c7901257945
Autor:
Sophie C. Frölke, BSc, Pim Bouwmans, MD, A. Lianne Messchendorp, MD, PhD, Suzanne E. Geerlings, MD, PhD, Marc H. Hemmelder, MD, PhD, Ron T. Gansevoort, MD, PhD, Luuk B. Hilbrands, MD, PhD, Marlies E.J. Reinders, MD, PhD, Jan-Stephan F. Sanders, MD, PhD, Frederike J. Bemelman, MD, PhD, Hessel Peters-Sengers, PhD, RECOVAC Collaborators
Publikováno v:
Transplantation Direct, Vol 8, Iss 11, p e1397 (2022)
Background. Kidney transplant recipients (KTRs) are still at risk of severe COVID-19 disease after SARS‑CoV‑2 vaccination, especially when they have limited antibody formation. Our aim was to understand the factors that may limit their humoral re
Externí odkaz:
https://doaj.org/article/f032a5736f2e47ffac77c7826f209baf
Autor:
Céline Imhof, MD, A. Lianne Messchendorp, MD, PhD, Marieke van der Heiden, PhD, Carla C. Baan, PhD, Renate G. van der Molen, PhD, Ester B. M. Remmerswaal, PhD, Rory D. de Vries, PhD, Dimitri A. Diavatopoulos, PhD, Annemarie Boerma, MSc, Femke J. Bakker, BSc, Emily Oosterhout, BSc, Frederike J. Bemelman, MD, PhD, Luuk B. Hilbrands, MD, PhD, Marlies E. J. Reinders, MD, PhD, Ron T. Gansevoort, MD, PhD, Jan-Stephan Sanders, MD, PhD, Debbie van Baarle, PhD, on behalf of RECOVAC Consortium
Publikováno v:
Transplantation Direct, Vol 8, Iss 11, p e1387 (2022)
Background. Studies have shown that coronavirus disease 2019 (COVID-19) vaccination is associated with a lower humoral response in vulnerable kidney patients. Here, we investigated the T-cell response following COVID-19 vaccination in kidney patients
Externí odkaz:
https://doaj.org/article/7afa0ccb8ef14bc0b3e6b150791cf86b
Autor:
Roman-Ulrich Müller, A. Lianne Messchendorp, Henrik Birn, Giovambattista Capasso, Emilie Cornec-Le Gall, Olivier Devuyst, Albertien van Eerde, Patrick Guirchoun, Tess Harris, Ewout J. Hoorn, Nine V.A.M. Knoers, Uwe Korst, Djalila Mekahli, Yannick Le Meur, Tom Nijenhuis, Albert C.M. Ong, John A. Sayer, Franz Schaefer, Aude Servais, Vladimir Tesar, Roser Torra, Stephen B. Walsh and Ron T. Gansevoort
Publikováno v:
Počki, Vol 11, Iss 1, Pp 37-39 (2022)
No abstract
Externí odkaz:
https://doaj.org/article/3f3763f45a78472d9048eb2d6d9503c1
Autor:
A. Lianne Messchendorp, Edwin M. Spithoven, Niek F. Casteleijn, Wendy A. Dam, Jacob van den Born, Wouter F. Tonnis, Carlo A. J. M. Gaillard, Esther Meijer, on behalf of the DIPAK Consortium
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Somatostatin (SST) inhibits intracellular cyclic adenosine monophosphate (cAMP) production and thus may modify cyst formation in autosomal dominant polycystic kidney disease (ADPKD). We investigated whether endogenous plasma SST c
Externí odkaz:
https://doaj.org/article/5ffdb32fedf24b4aa7465562d43628c9
Autor:
A. Lianne Messchendorp, Esther Meijer, Wendy E. Boertien, Gerwin E. Engels, Niek F. Casteleijn, Edwin M. Spithoven, Monique Losekoot, Johannes G.M. Burgerhof, Dorien J.M. Peters, Ron T. Gansevoort
Publikováno v:
Kidney International Reports, Vol 3, Iss 2, Pp 291-301 (2018)
The variable disease course of autosomal dominant polycystic kidney disease (ADPKD) makes it important to develop biomarkers that can predict disease progression, from a patient perspective and to select patients for renoprotective treatment. We ther
Externí odkaz:
https://doaj.org/article/6fc726da32f847b0a64eb14f8c80f143
Autor:
Marcia M L Kho, A Lianne Messchendorp, Sophie C Frölke, Celine Imhof, Vera JCH Koomen, S Reshwan K Malahe, Priya Vart, Daryl Geers, Rory D de Vries, Corine H GeurtsvanKessel, Carla C Baan, Renate G van der Molen, Dimitri A Diavatopoulos, Ester B M Remmerswaal, Debbie van Baarle, Rob van Binnendijk, Gerco den Hartog, Aiko P J de Vries, Ron T Gansevoort, Frederike J Bemelman, Marlies E J Reinders, Jan-Stephan F Sanders, Luuk B Hilbrands, Alferso C. Abrahams, Marije C. Baas, Pim Bouwmans, Marc A.G.J. ten Dam, Lennert Gommers, Dorien Standaar, Marieke van der Heiden, Yvonne M.R. Adema, Marieken J. Boer-Verschragen, Wouter B. Mattheussens, Ria H.L.A. Philipsen, Djenolan van Mourik, Susanne Bogers, Laura L.A. van Dijk, Nynke Rots, Gaby Smits, Marjan Kuijer, Marc H. Hemmelder
Publikováno v:
Lancet Infectious Diseases, 23, 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319
Lancet infectious diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23(3), 307-319. ELSEVIER SCI LTD
The Lancet Infectious Diseases, 23(3), 307-319. Lancet Publishing Group
Lancet Infectious Diseases, 23, 3, pp. 307-319
BACKGROUND: An urgent need exists to improve the suboptimal COVID-19 vaccine response in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with a control single dose mRNA-1273 vaccination: a double vaccine dose, he